News 2018-05-15
Join us at DCAT Week in New York City, March 19-22, 2018
DCAT Week is the premier global business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It is organized by the Drug, Chemical & Associated Technologies Association (DCAT) to enable strategic meetings between buyers and providers with the best networking opportunities. Porton’s meeting room will be located in the Vanderbilt Suite, 2nd Floor, Intercontinental Barclays New York Hotel, 111 East 48th Street, New York City. Contact our representatives today to schedule an appointment - we look forward to helping you develop impactful solutions across the value chain and life cycle!
Others
More
News 2025-03-21
Porton's Near-Term Target Validated by the SBTi
March 20, 2025, Chongqing—Porton Pharma Solutions Ltd. (Porton) announced today that its near-term greenhouse gas emissions reductions targets have been formally validated by the Science Based Targets initiative (SBTi). This milestone not only signifies its strategic breakthrough in climate governance, but also demonstrates that its decarbonization roadmap is aligned with the 1.5°C climate mitigation pathway.
News 2025-03-19
Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T Cell Therapy Development
Cranbury, New Jersey, March 19, 2025 — Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Eureka Therapeutics, Inc., a clinical-stage biotechnology company dedicated to developing novel T‑cell therapies for both solid tumors and hematologic malignancies.
